iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Significant Decrease in Short Interest

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) was the recipient of a large decrease in short interest in July. As of July 15th, there was short interest totaling 266,083 shares, a decrease of 40.0% from the June 30th total of 443,214 shares. Approximately 1.9% of the company’s stock are sold short. Based on an average daily volume of 440,124 shares, the short-interest ratio is currently 0.6 days.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Institutional investors have recently bought and sold shares of the company. Foundations Investment Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $54,513,000. BNP Paribas Financial Markets bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth $13,108,000. Anfield Capital Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $10,007,000. JPMorgan Chase & Co. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 89.4% during the fourth quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock worth $18,052,000 after purchasing an additional 100,426 shares during the last quarter. Finally, Cetera Investment Advisers boosted its holdings in iShares U.S. Pharmaceuticals ETF by 675.4% during the first quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after purchasing an additional 95,353 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 1.0%

Shares of iShares U.S. Pharmaceuticals ETF stock traded down $1.04 during trading on Thursday, reaching $102.46. The stock had a trading volume of 308,068 shares, compared to its average volume of 145,930. The company has a market capitalization of $1.60 billion, a price-to-earnings ratio of 17.75 and a beta of 0.49. The stock has a fifty day moving average price of $96.55 and a two-hundred day moving average price of $90.81. iShares U.S. Pharmaceuticals ETF has a 52 week low of $64.94 and a 52 week high of $105.02.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.